Prism Advisors Inc. bought a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 251 shares of the company’s stock, valued at approximately $207,000. Other large investors have also [...]
Prism Advisors Inc. Invests $207,000 in Eli Lilly and Company (NYSE:LLY)
